Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
5
×
boston top stories
life sciences
national blog main
national top stories
san francisco blog main
new york blog main
san francisco top stories
seattle blog main
boston
boulder/denver blog main
checkpoint inhibitors
detroit blog main
indiana blog main
medical devices
raleigh-durham blog main
san diego blog main
san francisco
seattle top stories
startups
texas blog main
wisconsin blog main
38 studios
accelerator
aidan petrie
alphabet
amy heimberer
bankruptcy
barrow neurological institute
ben and catherine ivy foundation
bio
biobucks
boston red sox
boulder/denver top stories
brain cancer
broad institute of harvard and mit
brook byers
calistoga pharmaceuticals
cancer
What
tiny
5
×
based
biosciences
cancer
drug
million
adding
alzheimer's
available
bad
begin
bets
better
big
bio
bio’s
boost
boston’s
brain
brings
bubbles
capital
cas
case
cells
cheaper
city
class
clinical
codiak
crispr
develop
diagnostics
disease
doses
exosome
exosomes
expects
expensive
failed
Language
unset
Current search:
tiny
×
" boston blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect
